ACTS
Price
$24.96
Change
-$0.36 (-1.42%)
Updated
Oct 16, 02:21 PM (EDT)
Net Assets
11.28M
Intraday BUY SELL Signals
BE
Price
$221.34
Change
-$14.96 (-6.33%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
77.42B
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACTS vs BE

ACTS vs BE Comparison Chart in %
View a ticker or compare two or three
VS
ACTS vs. BE commentary
Oct 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACTS is a Hold and BE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACTS with price predictions
Oct 15, 2026

ACTS's RSI Indicator ascending out of oversold territory

The RSI Oscillator for ACTS moved out of oversold territory on September 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +3.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACTS advanced for three days, in 24 of 31 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACTS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for ACTS turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 3 similar instances when the indicator turned negative. In 3 of the 3 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

ACTS moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

ACTS broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ACTS entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for BE with price predictions
Oct 16, 2026

BE in downward trend: price dove below 50-day moving average on October 14, 2026

BE moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend. In 31 of 36 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BE moved out of overbought territory on September 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 34 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BE as a result. In 63 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for BE turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in 266 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

BE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 235 of 259 cases where BE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (48.077) is very high in comparison to the industry average of (7.632). BE's P/E Ratio (341.390) is considerably higher than the industry average of (54.807). Projected Growth (PEG Ratio) (0.594) is also within normal values, averaging (2.900). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (8.019).

FUNDAMENTALS RATINGS
BE: Fundamental Ratings
BE
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
44
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACTSBE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 5 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
ACTS
Daily Signal:
Gain/Loss:
BE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR139.611.92
+1.39%
Extra Space Storage
CIA3.44-0.03
-0.86%
Citizens
OGG2.59-0.06
-2.26%
Osisko Gold Group Inc
RLAY16.28-1.02
-5.90%
Relay Therapeutics
VTGN0.20-0.01
-6.10%
VistaGen Therapeutics

ACTS and

Correlation & Price change

A.I.dvisor tells us that ACTS and CIEN have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTS and CIEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTS
1D Price
Change %
ACTS100%
-1.29%
CIEN - ACTS
12%
Poorly correlated
-6.67%
COHR - ACTS
11%
Poorly correlated
-7.06%
BE - ACTS
8%
Poorly correlated
-6.34%
GPOR - ACTS
8%
Poorly correlated
+1.37%
AEIS - ACTS
8%
Poorly correlated
-5.57%
More